Products for Research Use Only
RegisterLogin

HKI-357

CAT: 0804-HY-103443-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-103443-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HKI-357 is an irreversible dual inhibitor of EGFR and ERBB2 with IC50s of 34 nM and 33 nM, respectively. HKI-357 suppresses EGFR autophosphorylation (at Y1068), and AKT and MAPK phosphorylation[1].
CAS Number
848133-17-5
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/hki-357.html
Purity
99.24
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(NC1=C(OCC)C=C2N=CC(C#N)=C(NC3=CC=C(OCC4=CC=CC(F)=C4)C(Cl)=C3)C2=C1)/C=C/CN(C)C
Molecular Formula
C31H29ClFN5O3
Molecular Weight
574.05
References & Citations
[1]Kwak EL, et al. Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib. Proc Natl Acad Sci U S A. 2005 May 24;102 (21) :7665-70.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
EGFR/ErbB1/HER1; ErbB2/HER2

Related Products

CatalogName
HY-176438-01DDL-357
HY-W953282CRBN ligand-357
HY-117784BI-L-357
HY-107129MK-3577
HY-172458-01Z-3578
HY-107596-01SR-3576
HY-105523S 3578 (sulfate)
HY-115682-01(S) -ZINC-3573
HY-118069-01(R) -ZINC-3573
HY-RI04411A-01Rno-miR-3574 antagomir

Alternative Products

CatalogName
B5456-1HKI 357
BUP04975-01HKI-357
GTR19212201-01HKI-357 dimaleate
A8322-SNeratinib (HKI-272)
MBS131768-01Neratinib HKI 272
MBS577438Neratinib(HKI-272)
T210753-01DDL-357
A10638-500Neratinib (HKI-272) 500mg
A10638-50Neratinib (HKI-272) 50mg
T26812-01BI-L 357

Popular Products